000963 华东医药
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额2,610,8523,748,9293,929,2172,381,8533,169,758
投资活动产生之现金流量净额(1,078,392)(2,170,272)(1,750,552)(2,435,598)(1,986,683)
筹资活动产生之现金流量净额(2,362,638)(749,664)(1,393,361)(99,710)(767,453)
汇率变动对现金及现金等价物的影响(6,922)(47,002)5,946(9,775)7,112
现金及现金等价物净增加/(减少)(837,100)781,991791,249(163,230)422,734
期初现金及现金等价物余额4,990,1514,208,1603,416,9113,580,1413,157,407
期末现金及现金等价物余额4,153,0514,990,1514,208,1603,416,9113,580,141